Related Experiment Videos
[Neuroprotection against glaucoma remains a concept]
1Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, UK. neville.osborne@ophthalmology.oxford.ac.uk
Summary
Glaucoma affects 105 million globally. This study explores potential causes beyond high intraocular pressure (IOP), including neuroprotection and cellular damage theories, for better glaucoma treatment.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Context:
- Glaucoma, a leading cause of blindness, affects approximately 105 million people worldwide.
- Characterized by progressive optic neuropathy, it involves optic nerve head damage and retinal ganglion cell death.
- Elevated intraocular pressure (IOP) is a primary risk factor, but lowering IOP does not always halt disease progression.
Purpose:
- To investigate etiological factors beyond elevated IOP in glaucoma.
- To discuss the role of neuroprotective agents in glaucoma management.
- To explore theories of cellular damage, including cumulative and singular damage, in glaucoma pathogenesis.
Summary:
- Presents alternative etiological factors for glaucoma, moving beyond solely elevated IOP.
- Discusses the potential of neuroprotective agents in therapeutic strategies.
- Examines two key theories for ganglion cell death: cumulative damage (age-related toxin accumulation) and singular damage (mutant response genes).
Impact:
- Highlights the need for multifaceted approaches to glaucoma treatment.
- Suggests novel therapeutic avenues targeting cellular mechanisms.
- Provides insights into the complex pathophysiology of glaucoma, potentially benefiting patients with neurodegenerative diseases.